Загрузка...
Dornase alfa for cystic fibrosis
BACKGROUND: Dornase alfa is currently used as a mucolytic to treat pulmonary disease (the major cause of morbidity and mortality) in cystic fibrosis. It reduces mucus viscosity in the lungs, promoting improved clearance of secretions. This is an update of a previously published review. OBJECTIVES: T...
Сохранить в:
| Опубликовано в: : | Cochrane Database Syst Rev |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley & Sons, Ltd
2018
|
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6513278/ https://ncbi.nlm.nih.gov/pubmed/30187450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001127.pub4 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|